心力衰竭住院患者的居家时间、死亡率和再入院率:IMPLEMENT-HF 前的基线。

IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Circulation: Heart Failure Pub Date : 2024-10-01 Epub Date: 2024-10-09 DOI:10.1161/CIRCHEARTFAILURE.124.011795
Amber B Tang, Nicole Solomon, Karen Chiswell, Stephen J Greene, Clyde W Yancy, Mariell Jessup, Michelle Kittleson, Javed Butler, Nancy K Sweitzer, Lee R Goldberg, Jo-Ann Lindenfeld, Eldrin F Lewis, Pamela N Peterson, Sara Paul, Lynn Mallas Serdynski, Christine Rutan, Michelle Congdon, Sruthi Cherkur, Gregg C Fonarow
{"title":"心力衰竭住院患者的居家时间、死亡率和再入院率:IMPLEMENT-HF 前的基线。","authors":"Amber B Tang, Nicole Solomon, Karen Chiswell, Stephen J Greene, Clyde W Yancy, Mariell Jessup, Michelle Kittleson, Javed Butler, Nancy K Sweitzer, Lee R Goldberg, Jo-Ann Lindenfeld, Eldrin F Lewis, Pamela N Peterson, Sara Paul, Lynn Mallas Serdynski, Christine Rutan, Michelle Congdon, Sruthi Cherkur, Gregg C Fonarow","doi":"10.1161/CIRCHEARTFAILURE.124.011795","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Home-time is an emerging, patient-centered outcome that represents the amount of time a patient spends alive and outside of health care facility settings, comprising of hospitals, skilled nursing facilities, and acute rehabilitation centers. Studies evaluating home-time in the context of heart failure are limited, and the impact of quality improvement interventions on home-time has not been studied.</p><p><strong>Methods: </strong>Medicare beneficiaries aged 65 years or older who were hospitalized for heart failure in the Get With the Guidelines-Heart Failure registry between 2019 and 2021 were included. Postdischarge home-time, mortality, and readmission rates at 30 days and 1 year were calculated with the goal of establishing baseline metrics before the initiation of IMPLEMENT-HF, a multicenter quality improvement program aimed at improving heart failure management.</p><p><strong>Results: </strong>Overall, 66 019 patients were included across 437 sites. Median 30-day and 1-year home-time were 30 (18-30) and 333 (139-362) days, respectively. Only 22.1% of patients experienced 100% home-time in the year after discharge. Older patients spent significantly less time at home, with a median 1-year home-time of 302 (86-359) compared with 345 (211-365) days in patients over 85 and those between 65 and 74 years old, respectively (<i>P</i><0.001). Black patients also experienced the least amount of home-time with only 328 (151-360) days at 1-year follow-up. Rates of heart failure readmission and all-cause mortality 1-year post-discharge were high at 29.8% and 37.0%, respectively.</p><p><strong>Conclusions: </strong>In this contemporary multicenter cohort, patients hospitalized with heart failure spent a median of 91.2% of their time in the year after discharge alive and at home, largely driven by high mortality rates. These findings serve as a preimplementation baseline for IMPLEMENT-HF, which will evaluate the impact of targeted heart failure initiatives on home-time and other clinical outcomes.</p>","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e011795"},"PeriodicalIF":7.8000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11479851/pdf/","citationCount":"0","resultStr":"{\"title\":\"Home-Time, Mortality, and Readmissions Among Patients Hospitalized With Heart Failure: A Baseline Prior to IMPLEMENT-HF.\",\"authors\":\"Amber B Tang, Nicole Solomon, Karen Chiswell, Stephen J Greene, Clyde W Yancy, Mariell Jessup, Michelle Kittleson, Javed Butler, Nancy K Sweitzer, Lee R Goldberg, Jo-Ann Lindenfeld, Eldrin F Lewis, Pamela N Peterson, Sara Paul, Lynn Mallas Serdynski, Christine Rutan, Michelle Congdon, Sruthi Cherkur, Gregg C Fonarow\",\"doi\":\"10.1161/CIRCHEARTFAILURE.124.011795\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Home-time is an emerging, patient-centered outcome that represents the amount of time a patient spends alive and outside of health care facility settings, comprising of hospitals, skilled nursing facilities, and acute rehabilitation centers. Studies evaluating home-time in the context of heart failure are limited, and the impact of quality improvement interventions on home-time has not been studied.</p><p><strong>Methods: </strong>Medicare beneficiaries aged 65 years or older who were hospitalized for heart failure in the Get With the Guidelines-Heart Failure registry between 2019 and 2021 were included. Postdischarge home-time, mortality, and readmission rates at 30 days and 1 year were calculated with the goal of establishing baseline metrics before the initiation of IMPLEMENT-HF, a multicenter quality improvement program aimed at improving heart failure management.</p><p><strong>Results: </strong>Overall, 66 019 patients were included across 437 sites. Median 30-day and 1-year home-time were 30 (18-30) and 333 (139-362) days, respectively. Only 22.1% of patients experienced 100% home-time in the year after discharge. Older patients spent significantly less time at home, with a median 1-year home-time of 302 (86-359) compared with 345 (211-365) days in patients over 85 and those between 65 and 74 years old, respectively (<i>P</i><0.001). Black patients also experienced the least amount of home-time with only 328 (151-360) days at 1-year follow-up. Rates of heart failure readmission and all-cause mortality 1-year post-discharge were high at 29.8% and 37.0%, respectively.</p><p><strong>Conclusions: </strong>In this contemporary multicenter cohort, patients hospitalized with heart failure spent a median of 91.2% of their time in the year after discharge alive and at home, largely driven by high mortality rates. These findings serve as a preimplementation baseline for IMPLEMENT-HF, which will evaluate the impact of targeted heart failure initiatives on home-time and other clinical outcomes.</p>\",\"PeriodicalId\":10196,\"journal\":{\"name\":\"Circulation: Heart Failure\",\"volume\":\" \",\"pages\":\"e011795\"},\"PeriodicalIF\":7.8000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11479851/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Circulation: Heart Failure\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1161/CIRCHEARTFAILURE.124.011795\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation: Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/CIRCHEARTFAILURE.124.011795","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/9 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:居家时间是一种新兴的、以患者为中心的结果,它代表了患者在医疗机构(包括医院、专业护理机构和急性康复中心)之外的生存时间。评估心力衰竭患者居家时间的研究非常有限,而质量改进干预措施对居家时间的影响也尚未研究:方法:纳入 2019 年至 2021 年期间因心力衰竭住院的 65 岁及以上医疗保险受益人,这些受益人在 "按指南治疗-心力衰竭 "登记册中登记。计算了出院后的居家时间、死亡率以及 30 天和 1 年后的再入院率,目的是在启动旨在改善心衰管理的多中心质量改进计划 IMPLEMENT-HF 之前建立基线指标:共有 437 家医疗机构的 66 019 名患者参与其中。30天和1年居家时间的中位数分别为30天(18-30天)和333天(139-362天)。只有 22.1% 的患者在出院后的一年内有 100% 的居家时间。老年患者的居家时间明显较少,1年居家时间的中位数为302(86-359)天,而85岁以上和65-74岁患者的居家时间分别为345(211-365)天(结论:老年患者的居家时间明显较少,而85岁以上和65-74岁患者的居家时间分别为345(211-365)天):在这一当代多中心队列中,心力衰竭住院患者出院后一年中,有 91.2% 的时间是在家中度过的,主要原因是死亡率较高。这些研究结果是 IMPLEMENT-HF 项目实施前的基线,该项目将评估有针对性的心衰措施对居家时间和其他临床结果的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Home-Time, Mortality, and Readmissions Among Patients Hospitalized With Heart Failure: A Baseline Prior to IMPLEMENT-HF.

Background: Home-time is an emerging, patient-centered outcome that represents the amount of time a patient spends alive and outside of health care facility settings, comprising of hospitals, skilled nursing facilities, and acute rehabilitation centers. Studies evaluating home-time in the context of heart failure are limited, and the impact of quality improvement interventions on home-time has not been studied.

Methods: Medicare beneficiaries aged 65 years or older who were hospitalized for heart failure in the Get With the Guidelines-Heart Failure registry between 2019 and 2021 were included. Postdischarge home-time, mortality, and readmission rates at 30 days and 1 year were calculated with the goal of establishing baseline metrics before the initiation of IMPLEMENT-HF, a multicenter quality improvement program aimed at improving heart failure management.

Results: Overall, 66 019 patients were included across 437 sites. Median 30-day and 1-year home-time were 30 (18-30) and 333 (139-362) days, respectively. Only 22.1% of patients experienced 100% home-time in the year after discharge. Older patients spent significantly less time at home, with a median 1-year home-time of 302 (86-359) compared with 345 (211-365) days in patients over 85 and those between 65 and 74 years old, respectively (P<0.001). Black patients also experienced the least amount of home-time with only 328 (151-360) days at 1-year follow-up. Rates of heart failure readmission and all-cause mortality 1-year post-discharge were high at 29.8% and 37.0%, respectively.

Conclusions: In this contemporary multicenter cohort, patients hospitalized with heart failure spent a median of 91.2% of their time in the year after discharge alive and at home, largely driven by high mortality rates. These findings serve as a preimplementation baseline for IMPLEMENT-HF, which will evaluate the impact of targeted heart failure initiatives on home-time and other clinical outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Circulation: Heart Failure
Circulation: Heart Failure 医学-心血管系统
CiteScore
12.90
自引率
3.10%
发文量
271
审稿时长
6-12 weeks
期刊介绍: Circulation: Heart Failure focuses on content related to heart failure, mechanical circulatory support, and heart transplant science and medicine. It considers studies conducted in humans or analyses of human data, as well as preclinical studies with direct clinical correlation or relevance. While primarily a clinical journal, it may publish novel basic and preclinical studies that significantly advance the field of heart failure.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信